Notably, no significant increase in CD4+ and CD8+ tumor infiltrating T cells was observed between the PD-1 Ab-treated and isotype control-treated mice bearing LDH-A expressing B16-F10 tumors (Figure 2A,B). The gene discussed is CD4; the disease is neoplasm.